Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

REGNREGN
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in REGENERON PHARMACEUTICALS

GOLDMAN SACHS GROUP INC holds 1.2M shares of REGN (REGENERON PHARMACEUTICALS), worth $725.3M as of 2026-Q2. The position was decreased (-10.6% shares). REGN represents 0.1% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$725.3M

Current Shares

1.2M

Total Value Change

+$266.1M

Total Shares Change

+518,554

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.2M
-10.6%
$725.3M0.1%$622.81
0
2026-Q1
Increased
1.3M
+18.5%
$1B0.1%$770.59
45
2025-Q4
Increased
1.1M
+15.2%
$847M0.1%$768.90
44
2025-Q3
Increased
952,839
+19.7%
$535.8M0.1%$559.40
37
2025-Q2
Decreased
796,206
-4.9%
$418M0.1%$521.53
0
2025-Q1
Increased
837,093
+29.9%
$530.9M0.1%$629.11
40
2024-Q4
New
644,637
-
$459.2M0.1%$705.67
43

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used